Frontlight ResearchEarly access
Trial site
Nantong
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia1 trial
- Chronic spontaneous urticaria1 trial
- Diabetic eye disease1 trial
- Familial hypercholesterolaemia1 trial
- IgA nephropathy1 trial
- Macular degeneration1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026